title: Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis.
abstract: Morphologic changes in the pituitary, liver, and pancreas of mice with the metallothionein-human growth hormone--releasing hormone (MT-hGRH) transgene were analyzed by in situ hybridization histochemistry (ISH). There was progression from somatotroph hyperplasia to neoplasia in pituitaries of transgenic mice. Pituitary neoplasms were present between 9 to 12 months of age in some mice. Magnetic resonance imaging (MRI) readily identified enlarged pituitaries in MT-hGRH transgenic mice. Serum mouse GH and hGRH levels were marked elevated in MT-hGRH transgenic mice. In situ hybridization histochemistry showed mRNA for hGRH in liver, pituitary, pancreas, spleen, and in most other tissues examined. Combined ISH and immunohistochemistry in the pituitary gland showed that some of the GH cells also produced hGRH, and ultrastructural immunohistochemical analysis of pituitaries showed that GH and hGRH were localized in the same cell and within the same secretory granules. Liver cells of MT-hGRH transgenic mice showed evidence of hypertrophy, and the pancreatic islets were hyperplastic with significant increases in the islet cell areas. The morphologic changes in the liver were distinctive enough to separate control littermates from MT-hGRH transgenic mice in all cases. The enlarged pancreatic islets had increased numbers of insulin-producing cells. Immunoreactive hGRH and hGRH mRNA were both localized in islet cells, and an intense hybridization signal of hGRH mRNA, but only weak staining for hGRH protein, were detected in the liver of transgenic mice. These results indicate that excessive hGRH production leads to distinct morphologic changes in various organs in MT-hGRH transgenic mice and that there is temporal progression from hyperplasia to adenomatous somatotrophs in pituitaries with chronic stimulation by hGRH that involves paracrine, endocrine, and autocrine mechanisms.
authors.affiliation: Department of Pathology, University of Michigan Medical Center, Ann Arbor.
authors.forename: R V
authors.initials: RV
authors.lastname: Lloyd
authors.forename: L
authors.initials: L
authors.lastname: Jin
authors.forename: A
authors.initials: A
authors.lastname: Chang
authors.forename: E
authors.initials: E
authors.lastname: Kulig
authors.forename: S A
authors.initials: SA
authors.lastname: Camper
authors.forename: B D
authors.initials: BD
authors.lastname: Ross
authors.forename: T R
authors.initials: TR
authors.lastname: Downs
authors.forename: L A
authors.initials: LA
authors.lastname: Frohman
mesh_terms: D000236:Adenoma / Q000209:etiology*; D000818:Animals; D013007:Growth Hormone-Releasing Hormone / Q000235:genetics / Q000502:physiology*; D006729:Hormones, Ectopic / Q000494:pharmacology; D006965:Hyperplasia; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008668:Metallothionein / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D010179:Pancreas / Q000187:drug effects / Q000473:pathology*; D010902:Pituitary Gland / Q000187:drug effects / Q000473:pathology*; D010911:Pituitary Neoplasms / Q000209:etiology*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology
chemical_list: D006729:Hormones, Ectopic; D011993:Recombinant Fusion Proteins; D013007:Growth Hormone-Releasing Hormone; D008668:Metallothionein